US Praises Mexico for Taking Down Top Drug Lord
Nemesio Oseguera Cervantes, also known as El Mencho, was wounded during a joint operation led by the Mexican army in Tapalpa, Jalisco, and later died while being transported to Mexico City, the Defense Ministry said. He headed the Jalisco New Generation Cartel, one of Mexico’s most powerful criminal organizations and a major alleged supplier of fentanyl, cocaine, and methamphetamines to the US. The cartel was designated a foreign terrorist organization by Washington last year, and Oseguera had rewards of up to $15 million for information leading to his capture.
“I’ve just been informed that Mexican security forces have killed ‘El Mencho,’ one of the bloodiest and most ruthless drug kingpins. This is a great development for Mexico, the US, Latin America, and the world,” US Deputy Secretary of State Christopher Landau wrote on X. He added, “the good guys are stronger than the bad guys.”
White House Press Secretary Karoline Leavitt described Cervantes as “an infamous drug lord” and confirmed US intelligence support for the operation. “‘El Mencho’ was a top target for the Mexican and United States governments as one of the top traffickers of fentanyl into our homeland,” she wrote, thanking “the Mexican military for their cooperation and successful execution of this operation.”
Mexican authorities said troops came under fire during the raid. Several suspected cartel members were killed, others were wounded or arrested, and weapons—including armored vehicles and rocket launchers—were seized.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
